Brexit: The waiting game
As lawyers and industry prepare for a possible no-deal Brexit, the uncertainty surrounding its impact runs like a core through the industry, as LSIPR’s Saman Javed discovers.
Latest news
CRISPR Therapeutics to buy JV from Bayer
22-10-2019
A joint venture between gene-editing startup CRISPR Therapeutics and German pharmaceutical company Bayer will come under the control of CRISPR Therapeutics, according to the pair’s proposed plans.
50 Key Influencers In The Life Sciences
- LSIPR 50 2018: Robert Nelsen 05-09-2018
- LSIPR 50 2018: Stephen Knight 04-09-2018
Regions
Sectors
